NWM
VRTX icon

Nova Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Nova Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98K Hold
14
– – ﹤0.01% 425
2026
Q1 		$6.28K Hold
14
– – ﹤0.01% 410
2025
Q4 		$6.37K Hold
14
– – ﹤0.01% 398
2025
Q3 		$5.51K Hold
14
– – ﹤0.01% 403
2025
Q2 		$6.26K Sell
14
-2
-13% -$922 ﹤0.01% 414
2025
Q1 		$7.76K Buy
+16
New +$7.46K 0.01% 346

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Nova Wealth Management's VRTX Position: Q2 2026 in Review

Nova Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 14 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Nova Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.76K in Q1 2025. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Nova Wealth Management held 14 shares of Vertex Pharmaceuticals worth $6.98K as of Q2 2026.
  • Nova Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Nova Wealth Management's portfolio in Q2 2026, its #425 holding.
  • Nova Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Nova Wealth Management's Vertex Pharmaceuticals position peaked at $7.76K in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.